Live Breaking News & Updates on Translational cancer research network

Stay informed with the latest breaking news from Translational cancer research network on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Translational cancer research network and stay connected to the pulse of your community

2022 Australia Day Awards » J-Wire

The 2022 awards see work with climate change being acknowledged and a wife and husband team making the list. COMPANION (AC) IN THE GENERAL DIVISION OF THE ORDER OF AUSTRALIA Dr Alan Simon FINKEL AO, South Yarra VIC 3141 For eminent service to science, to national energy innovation and research infrastructure capability, to climate change and COVID-19…

Jerusalem , Israel-general- , Israel , Toomelah , New-south-wales , Australia , United-states , Petropolis , Estado-do-rio , Brazil , Hong-kong , Banksia

Changes in systemic cancer therapy in Australia during the COVID-19 pandemic: a population-based study

Changes in systemic cancer therapy in Australia during the COVID-19 pandemic: a population-based study
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

New-york , United-states , Australia , New-zealand , United-kingdom , Sydney , New-south-wales , Northern-ireland , Craigavon , Australian , Scotland , Australians

UNSW Sydney and the Garvan Institute of Medical Research researchers will lead the program, thanks to a $3.75 million grant from the Cancer Institute NSW

Share
A national clinical trial program will test promising new targeted therapies for pancreatic cancer, one of the deadliest forms of cancers of which more than 3000 cases are diagnosed annually in Australia.
The clinical trial program (MoST–P), led by researchers and clinicians at UNSW and the Garvan Institute, will provide patients with access to either targeted therapies matched to the genomic signature of their individual tumour, or targeted to the tumour environment.
UNSW Dean of Medicine & Health, Professor Vlado Perkovic said the grant could lead to better outcomes for pancreatic cancer patients and more personalised approaches to treatment.
“Our researchers constantly challenge existing knowledge on cancer and are at the forefront of advances in cancer research. The trial announced today is an exciting development in pancreatic cancer research and offers hope for the future for people affected by this terrible disease,” Prof. Perkovic said.

Australia , Sydney , New-south-wales , Australians , Australian , Marina-pajic , David-goldstein , Ursula-sansom-daly , Christina-signorelli , Vlado-perkovic , Catherine-caldon , Paul-timpson

Pancreatic cancer clinical trial program to target genome and scar tissue

UNSW Sydney and the Garvan Institute of Medical Research researchers will lead the program, thanks to a $3.75 million grant from the Cancer Institute...

Australia , Sydney , New-south-wales , Australians , Australian , Marina-pajic , David-goldstein , Ursula-sansom-daly , Christina-signorelli , Vlado-perkovic , Catherine-caldon , Paul-timpson